Lilly Pharma Holding GmbH
- Pharmaceutical Sales 2009
-
Worldwide: 20.38 billion US $
Germany: 591.3 million Euro
- Product Range
- Medical products to treat cancer, diseases of the central nervous system like depression, schizophrenia, ADHD and Parkinson, endocrinologic diseases such as diabetes, osteoporosis and growth disorders, urological diseases such as erectile dysfunction and stress urinary incontinence, as well as diuretics, medical products to treat cardiovascular diseases, infections, severe sepsis
- Key Research Areas
- Endocrinology, Neuroscience, Cardiovascular and Oncology
- R&D Expenditure 2009
-
Worldwide: 4.3 billion US $
in Germany: -
- Employees in the Pharmaceuticals Division 2008
-
Worldwide: 40,360
in Germany: 1,000
(All data based on corporate information, as of: 05/2010)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page